About
CRISPR Medicine News (CMN) has been chronicling the rapid rise of gene editing since 2018, following CRISPR’s transformation from a revolutionary tool to a real-world therapy—culminating in the first-ever approved CRISPR-based treatment in 2023.
We provide in-depth, expert-written coverage across gene-editing technologies, delivery systems, in vivo applications, pre-clinical and clinical developments, and safety innovations. Our reporting is driven by scientific rigor and reviewed by the experts we interview.
Subscribers stay current through our CMN Weekly Newsletter, regular CMN Briefs,CMN Special and CMN Interviews that feature the most recent and interesting research, frequent CMN Clinical Trial Updates, and a continually updated CRISPR Medicine Clinical Trials register. Our CMN Webinars and CMN Live interviews further ensure that readers at every level can access critical insights.
In 2021 we launched WeDoCRISPR (WDC)—the world’s first CRISPR-focused community for students and early-career scientists. Through engaging explainers, videos, and visuals, WDC makes CRISPR accessible and exciting for the next generation of genome editors. WDC is managed by Martina Franchini, PhD., Antonio Carusillo, PhD., and Manel Llado Santaeularia, PhD.
Each year, our efforts culminate in the CRISPR Medicine Conference (CRISPRMED) in Copenhagen, where global leaders in CRISPR medicine connect, collaborate, and chart the path forward.
Join us to stay informed, inspired, and involved in shaping the future of CRISPR medicine.
Our Mission
To foster innovation in CRISPR Medicine by providing accessible, accurate information to the field.
Our content serves a sophisticated global audience of biopharma executives, investors, researchers, healthcare professionals, regulatory bodies, infrastructures and patients and their advocates, working to bring novel treatments to those who need them the most.
We’re created by COBO Technologies
CRISPR Medicine News is part of CRISPR Medicine Media Aps – founded in 2019 by Jens-Ole Bock, co-founder COBO Technologies.
CRISPR Medicine News is managed by experienced science writer and editor Gorm Palmgren, PhD.
All content is based on well-researched and well-documented information.
Contact us
Email: theeditor@crisprmedicinenews.com
Intellectual property rights
Unless otherwise indicated, the content on the CRISPR Medicine News site is copyright of CRISPR Medicine News.
Gorm Palmgren, PhD
Editor in Chief
Gorm has a Ph.D. in Cell Biology and has worked as a freelance science journalist since 2001. He started writing for CRISPR Medicine News in 2020 and still contributes with articles and updates after stepping up as Editor in Chief in 2025. With more than 600 feature articles in magazines, books and on the web, he covers most natural and technical sciences including medicine, genetics, neurology, biotechnology, computer science and technology. Gorm is member of the board in Danish Science Journalists Association.
Rasmus Kragh Jakobsen
Science Editor, Co-founder
Rasmus studied biochemistry at the University of Copenhagen.
Though he has a deep affection for Drosophila and developmental biology he found an even deeper satisfaction swapping the Gilson pipette for a keyboard.
His editorial career began in 2001 as the science editor at the Danish daily Information and he has been writing and editing about science, technology, and society ever since.
Advisors
Christina Blaagaard Collignon
Originally trained as a journalist and with a background in news reporting, Christina Blaagaard has spent over 20 years in the media through the disruption of an industry which was one of the first to be hit by the full force of digital transformation of both product and business model. She has worked in some of the biggest Danish and Scandinavian media organisations, now serving as CEO for Technologiens Mediehus. She also serves on the board of trade organisations, Danske Medier and Technology Denmark.
